GR3023242T3 - Process for the preparation of solid sustained release pharmaceutical forms - Google Patents

Process for the preparation of solid sustained release pharmaceutical forms

Info

Publication number
GR3023242T3
GR3023242T3 GR970400907T GR970400907T GR3023242T3 GR 3023242 T3 GR3023242 T3 GR 3023242T3 GR 970400907 T GR970400907 T GR 970400907T GR 970400907 T GR970400907 T GR 970400907T GR 3023242 T3 GR3023242 T3 GR 3023242T3
Authority
GR
Greece
Prior art keywords
binder
pharmaceutically acceptable
active substance
preparation
sustained release
Prior art date
Application number
GR970400907T
Other languages
English (en)
Inventor
Sven Dr Grabowski
Astrid Dr Kah-Helbig
Axel Dr Sanner
Kurt Dr Wendel
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of GR3023242T3 publication Critical patent/GR3023242T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR970400907T 1992-06-25 1997-04-22 Process for the preparation of solid sustained release pharmaceutical forms GR3023242T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4220782A DE4220782A1 (de) 1992-06-25 1992-06-25 Verfahren zur Herstellung von festen pharmazeutischen Retardformen

Publications (1)

Publication Number Publication Date
GR3023242T3 true GR3023242T3 (en) 1997-07-30

Family

ID=6461767

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400907T GR3023242T3 (en) 1992-06-25 1997-04-22 Process for the preparation of solid sustained release pharmaceutical forms

Country Status (10)

Country Link
US (1) US5490990A (el)
EP (1) EP0575930B1 (el)
JP (1) JP3619531B2 (el)
AT (1) ATE149826T1 (el)
CA (1) CA2098667C (el)
DE (2) DE4220782A1 (el)
DK (1) DK0575930T3 (el)
ES (1) ES2099318T3 (el)
GR (1) GR3023242T3 (el)
MX (1) MX9303604A (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
DE69617245T2 (de) * 1995-08-17 2002-07-25 Csir, Pretoria Produkte mit gesteuerter freisetzung
JPH1050306A (ja) * 1996-07-31 1998-02-20 Toyota Autom Loom Works Ltd 水素吸蔵合金電極の製造方法
AT403914B (de) * 1996-09-24 1998-06-25 Krems Chemie Ag Sprühgetrocknete dispersionen, verfahren zu ihrer herstellung und deren anwendung
DE19709532A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
DE19709663A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
DE10014588A1 (de) 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
FR2811227A1 (fr) * 2000-07-07 2002-01-11 Philippe Maincent Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs
US8257744B2 (en) * 2000-07-07 2012-09-04 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
AU2738302A (en) 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP2007519801A (ja) * 2004-02-05 2007-07-19 エルジー・ケム・リミテッド 液体微粒子をシードとする乳化重合方法
NZ550942A (en) * 2004-05-04 2011-02-25 Innophos Inc Directly compressible tricalcium phosphate
US8168219B2 (en) * 2005-11-30 2012-05-01 Isp Investments Inc. Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability
CA2669938C (en) * 2006-11-15 2016-01-05 Abbott Laboratories Solid pharmaceutical dosage formulations
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27107E (en) * 1968-05-01 1971-03-30 Drug composition
US3784648A (en) * 1971-10-01 1974-01-08 Wacker Chemie Gmbh Process for the preparation of free-flowing,lump-free,redispersible,synthetic resin powders
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE3143071A1 (de) * 1981-10-30 1983-05-11 Basf Ag, 6700 Ludwigshafen Verfahren zum herstellen von blockfesten, in wasser redispergierbaren polymerisat-pulvern durch verspruehen von waessrigen polymerisat-dispersionen
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
DE3344242A1 (de) * 1983-12-07 1985-06-20 Wacker-Chemie GmbH, 8000 München Verfahren zur herstellung eines redispergierbaren dispersionspulvers und seine anwendung
DE3438291A1 (de) * 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
DE3719241A1 (de) * 1987-06-06 1988-12-15 Roehm Gmbh Spruehgetrocknetes emulsionspolymerisat, verfahren zu seiner herstellung und verwendung und daraus bereitete formmasse
DE3723668A1 (de) * 1987-07-17 1989-01-26 Roehm Gmbh Staubarmes spruehgetrocknetes emulsionspolymerisat und verfahren zu seiner herstellung und anwendung
US5025004A (en) * 1988-06-13 1991-06-18 Eastman Kodak Company Water-dispersible polymeric compositions
DE3923229A1 (de) * 1989-07-14 1991-01-24 Basf Ag In wasser redispergierbare polymerisat-pulver, die durch verspruehen von waessrigen polymerisat-dispersionen hergestellt sind, und ihre verwendung als zusatzmittel zu hydraulischen bindemitteln
DE4133192A1 (de) * 1991-10-07 1993-04-08 Basf Ag Verfahren zum ueberziehen von arzneiformen

Also Published As

Publication number Publication date
EP0575930A1 (de) 1993-12-29
JP3619531B2 (ja) 2005-02-09
MX9303604A (es) 1994-06-30
EP0575930B1 (de) 1997-03-12
JPH0656651A (ja) 1994-03-01
US5490990A (en) 1996-02-13
DE4220782A1 (de) 1994-01-05
ES2099318T3 (es) 1997-05-16
DE59305700D1 (de) 1997-04-17
ATE149826T1 (de) 1997-03-15
CA2098667C (en) 2003-10-28
CA2098667A1 (en) 1993-12-26
DK0575930T3 (da) 1997-04-01

Similar Documents

Publication Publication Date Title
GR3023242T3 (en) Process for the preparation of solid sustained release pharmaceutical forms
AU560829B2 (en) Continuous release pharmaceutical compositions
FI934563A7 (fi) Polyvinyyliasetaaleja, jotka voivat muodostaa emulgaattorivapaita vesidispersioita ja uudelleen dispergoitavia kuivia jauheita, menetelmä niiden valmistamiseksi ja niiden käyttö
HUP0003121A3 (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
NO985094D0 (no) Polymerpulver som er redispergerbart i vandige l°sninger
CA2307018A1 (en) Osmotic medicament releasing system
EP0388954A3 (en) Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
ATE133862T1 (de) Arzneimittel mit verzögerter freigabe
SI0868912T1 (en) Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms
CS305091A3 (en) Pharmaceutical free of a solvent for per oral administration with delayed liberation of an active component and process for preparing thereof
EP0377517A3 (en) Theophylline dosage form
TW223592B (el)
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
AU640725B2 (en) Spray drying process for making pharmaceutical powder compositions directly compressible into tablets
HU900201D0 (en) Antiparasitic, insecticide, acaricide or nematicide compositions comprising 2,2-dimethyl-3-(2-monohaloethenyl)-cyclopropane-carboxylicacid derivatives as active ingredient and process for preparation thereof
HU896803D0 (en) Antiparasitic, insecticide, acaricide and nematicide compositions comprising fluor derivatives of 3-ethinyl-2,2-dimethyl cyclopropane carboxylic acid as active ingredient and process for preparation thereof
GEP19991819B (en) Method for Production of Therapeutic Form of Carbamazepin with Retarded Active Substance Release
JPS6429438A (en) Polyvinyl alcohol film
CA2105002A1 (en) The production of pellets composed of an ephedrine derivative
EP0285871A3 (en) Sustained release granulate without binding agent
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
AU4545289A (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
MY101266A (en) Pharmaceutical formulations
PT72397A (en) Process for the preparation of n,n-dialkyl-o-(pyrazol-5-yl)-carbamic acid derivatives and insecticide and nematicidecompositions thereof
WO1998019684A3 (de) Herstellung von trockenen lactulose-arzneiformen